Completed PHASE4 INTERVENTIONAL 2-arm
NCT04652648
Rapid Development and Implementation of a Remote ECG-monitored Prospective Randomized Clinical Trial During a Pandemic: Hydroxychloroquine Prophylaxis in COVID-19 Household Contacts
Sponsor: Bryn Mawr Hospital
Interventions
Hydroxychloroquine
Updated 3 times since 2021 Last updated: Dec 2, 2020 Started: May 27, 2020 Primary completion: Oct 31, 2020 Completion: Nov 15, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT04652648, this PHASE4 trial focuses on Coronavirus Infection and Covid19 and remains completed. Sponsored by Bryn Mawr Hospital, it has been updated 3 times since 2020, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
First recorded
May 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Bryn Mawr Hospital
- Bryn Mawr Hospital Foundation
- Cotswold Foundation
- Sharpe-Strumia Research Foundation
Data source: Bryn Mawr Hospital
For direct contact, visit the study record on ClinicalTrials.gov .